13 Tabellen nedenfor viser bivirkninger hos ORACEA- patienter i de pivotale, kliniske forsøg, dvs. bivirkninger, hvor hyppigheden i ORACEA- gruppen var højere end hyppigheden i placebo- gruppen (med ≥ 1%).
The table below lists adverse reactions on ORACEA in the pivotal clinical trials, ie adverse reactions for which the frequency on ORACEA was greater than the frequency on placebo (by ≥ 1%).